Efficacy and Safety of the LovenoxTM (Enoxaparin) Versus HeparinTM Gynecologic Oncology Patients

NCT01356329 · clinicaltrials.gov ↗

PHASE3

Phase

SUSPENDED

Status

150

Enrollment

OTHER_GOV

Sponsor class

Stopped Difficulty in enrolling patients

Conditions

Malignant Female Reproductive System Neoplasm

Interventions

DRUG: Enoxaparin, Heparin

Sponsor

National Guard Health Affairs